Sign In
Buy SMMT
$15.07
+0.210 (+1.41%)
At Close: Jun 03, 2026
Summit Therapeutics: Mid-2025 NSCLC Data Could Further Entrench Ivonescimab Program
03:33pm, Monday, 24'th Feb 2025
Summit Therapeutics: Mid-2025 NSCLC Data Could Further Entrench Ivonescimab Program
Pfizer: What The Summit Therapeutics Deal Brings
10:53am, Monday, 24'th Feb 2025
Pfizer: What The Summit Therapeutics Deal Brings
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on operational progr
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel, investigational
3 Stocks That Could Trounce the Market in 2025
04:32am, Monday, 17'th Feb 2025
If you're content with market-level returns, investing in an exchange-traded fund (ETF) is the way to go. But if not, you'll need to find stocks that hold the potential to pack more punch.
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 14'th Feb 2025
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
Is Summit Therapeutics a Millionaire Maker?
06:15am, Sunday, 09'th Feb 2025
Few companies in the biotech industry have performed better in the past two years than Summit Therapeutics (SMMT -2.71%). The drugmaker's shares are up by nearly 540%, thanks to excellent clinical pro
2 Stocks That Could Soar Again in 2025
08:50am, Saturday, 08'th Feb 2025
Many companies in the biotech industry performed well last year. Two in particular stood out: Viking Therapeutics (VKTX 3.50%) and Summit Therapeutics (SMMT -2.71%).
Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock?
09:15am, Thursday, 30'th Jan 2025
It can be exciting to buy a stock that has been red hot and to jump on the bandwagon -- but doing so can come with significant risks. At some point, there's a danger that the stock's rally could dissi
3 Unstoppable Stocks to Buy That Wall Street Thinks Will Soar More Than 35%
05:47am, Thursday, 23'rd Jan 2025
Just because Wall Street likes a stock doesn't mean it's a great pick. However, it's not a bad idea to at least consider how analysts view a given stock.
Why Summit Therapeutics Stock Is Jumping Today
12:06pm, Tuesday, 21'st Jan 2025
Shares of Summit Therapeutics (SMMT 15.40%) had jumped 14.3% at 11:31 a.m. ET on Tuesday.
Summit Therapeutics: Data Signals A Potential Paradigm Shift In NSCLC (Rating Upgrade)
09:33am, Saturday, 18'th Jan 2025
Summit Therapeutics' stock rose 888% since September 2023, driven by positive Phase 3 data for ivonescimab showing superior PFS vs Keytruda in NSCLC. Phase 3 HARMONi-2 trial showed 11.14 vs 5.82 month
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Thursday, 16'th Jan 2025
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
Why Summit Therapeutics Rocketed 584% in 2024
09:35am, Wednesday, 15'th Jan 2025
Shares of biotech Summit Therapeutics (SMMT -8.39%) skyrocketed 583.7% in 2024, according to data from S&P Global Market Intelligence.
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
06:10pm, Monday, 13'th Jan 2025
This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 bil
